Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Interrogating TGF-β Function and Regulation in Endothelial Cells.

Maring JA, van Meeteren LA, Goumans MJ, Ten Dijke P.

Methods Mol Biol. 2016;1344:193-203. doi: 10.1007/978-1-4939-2966-5_11.

PMID:
26520125
2.

NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation.

Koch S, van Meeteren LA, Morin E, Testini C, Weström S, Björkelund H, Le Jan S, Adler J, Berger P, Claesson-Welsh L.

Dev Cell. 2014 Mar 31;28(6):633-46. doi: 10.1016/j.devcel.2014.02.010. Epub 2014 Mar 20.

3.

ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis.

Liu Z, Lebrin F, Maring JA, van den Driesche S, van der Brink S, van Dinther M, Thorikay M, Martin S, Kobayashi K, Hawinkels LJ, van Meeteren LA, Pardali E, Korving J, Letarte M, Arthur HM, Theuer C, Goumans MJ, Mummery C, ten Dijke P.

PLoS One. 2014 Jan 28;9(1):e86273. doi: 10.1371/journal.pone.0086273. eCollection 2014.

4.

GATA2 and Lmo2 control angiogenesis and lymphangiogenesis via direct transcriptional regulation of neuropilin-2.

Coma S, Allard-Ratick M, Akino T, van Meeteren LA, Mammoto A, Klagsbrun M.

Angiogenesis. 2013 Oct;16(4):939-52. doi: 10.1007/s10456-013-9370-9. Epub 2013 Jul 28.

5.

Transforming growth factor β family members in regulation of vascular function: in the light of vascular conditional knockouts.

Jakobsson L, van Meeteren LA.

Exp Cell Res. 2013 May 15;319(9):1264-70. doi: 10.1016/j.yexcr.2013.02.015. Epub 2013 Feb 27. Review.

PMID:
23454603
6.

The polybasic insertion in autotaxin α confers specific binding to heparin and cell surface heparan sulfate proteoglycans.

Houben AJ, van Wijk XM, van Meeteren LA, van Zeijl L, van de Westerlo EM, Hausmann J, Fish A, Perrakis A, van Kuppevelt TH, Moolenaar WH.

J Biol Chem. 2013 Jan 4;288(1):510-9. doi: 10.1074/jbc.M112.358416. Epub 2012 Nov 13.

7.

Autotaxin in embryonic development.

Moolenaar WH, Houben AJ, Lee SJ, van Meeteren LA.

Biochim Biophys Acta. 2013 Jan;1831(1):13-9. doi: 10.1016/j.bbalip.2012.09.013. Epub 2012 Sep 28. Review.

PMID:
23022664
8.

Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting.

van Meeteren LA, Thorikay M, Bergqvist S, Pardali E, Stampino CG, Hu-Lowe D, Goumans MJ, ten Dijke P.

J Biol Chem. 2012 May 25;287(22):18551-61. doi: 10.1074/jbc.M111.338103. Epub 2012 Apr 5.

9.

Regulation of endothelial cell plasticity by TGF-β.

van Meeteren LA, ten Dijke P.

Cell Tissue Res. 2012 Jan;347(1):177-86. doi: 10.1007/s00441-011-1222-6. Epub 2011 Aug 25. Review.

10.

TGF-β receptor signaling pathways in angiogenesis; emerging targets for anti-angiogenesis therapy.

van Meeteren LA, Goumans MJ, ten Dijke P.

Curr Pharm Biotechnol. 2011 Dec;12(12):2108-20. Review.

PMID:
21619534
11.

Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid.

Dusaulcy R, Rancoule C, Grès S, Wanecq E, Colom A, Guigné C, van Meeteren LA, Moolenaar WH, Valet P, Saulnier-Blache JS.

J Lipid Res. 2011 Jun;52(6):1247-55. doi: 10.1194/jlr.M014985. Epub 2011 Mar 18.

12.

Structural basis of substrate discrimination and integrin binding by autotaxin.

Hausmann J, Kamtekar S, Christodoulou E, Day JE, Wu T, Fulkerson Z, Albers HM, van Meeteren LA, Houben AJ, van Zeijl L, Jansen S, Andries M, Hall T, Pegg LE, Benson TE, Kasiem M, Harlos K, Kooi CW, Smyth SS, Ovaa H, Bollen M, Morris AJ, Moolenaar WH, Perrakis A.

Nat Struct Mol Biol. 2011 Feb;18(2):198-204. doi: 10.1038/nsmb.1980. Epub 2011 Jan 16.

13.

Mammalian cell expression, purification, crystallization and microcrystal data collection of autotaxin/ENPP2, a secreted mammalian glycoprotein.

Hausmann J, Christodoulou E, Kasiem M, De Marco V, van Meeteren LA, Moolenaar WH, Axford D, Owen RL, Evans G, Perrakis A.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Sep 1;66(Pt 9):1130-5. doi: 10.1107/S1744309110032938. Epub 2010 Aug 31.

14.

A mutated soluble neuropilin-2 B domain antagonizes vascular endothelial growth factor bioactivity and inhibits tumor progression.

Geretti E, van Meeteren LA, Shimizu A, Dudley AC, Claesson-Welsh L, Klagsbrun M.

Mol Cancer Res. 2010 Aug;8(8):1063-73. doi: 10.1158/1541-7786.MCR-10-0157. Epub 2010 Jul 22.

15.

Discovery and optimization of boronic acid based inhibitors of autotaxin.

Albers HM, van Meeteren LA, Egan DA, van Tilburg EW, Moolenaar WH, Ovaa H.

J Med Chem. 2010 Jul 8;53(13):4958-67. doi: 10.1021/jm1005012.

PMID:
20536182
16.

Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation.

Albers HM, Dong A, van Meeteren LA, Egan DA, Sunkara M, van Tilburg EW, Schuurman K, van Tellingen O, Morris AJ, Smyth SS, Moolenaar WH, Ovaa H.

Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7257-62. doi: 10.1073/pnas.1001529107. Epub 2010 Apr 1.

17.

Vascular endothelial growth factor B controls endothelial fatty acid uptake.

Hagberg CE, Falkevall A, Wang X, Larsson E, Huusko J, Nilsson I, van Meeteren LA, Samen E, Lu L, Vanwildemeersch M, Klar J, Genove G, Pietras K, Stone-Elander S, Claesson-Welsh L, Ylä-Herttuala S, Lindahl P, Eriksson U.

Nature. 2010 Apr 8;464(7290):917-21. doi: 10.1038/nature08945. Epub 2010 Mar 14.

PMID:
20228789
18.

Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis.

Pamuklar Z, Federico L, Liu S, Umezu-Goto M, Dong A, Panchatcharam M, Fulkerson Z, Berdyshev E, Natarajan V, Fang X, van Meeteren LA, Moolenaar WH, Mills GB, Morris AJ, Smyth SS.

J Biol Chem. 2009 Mar 13;284(11):7385-94. doi: 10.1074/jbc.M807820200. Epub 2009 Jan 12. Erratum in: J Biol Chem. 2009 Jul 31;284(31):21100. Fulerson, Zachary [corrected to Fulkerson, Zachary].

19.

Suppression of the p53-dependent replicative senescence response by lysophosphatidic acid signaling.

Kortlever RM, Brummelkamp TR, van Meeteren LA, Moolenaar WH, Bernards R.

Mol Cancer Res. 2008 Sep;6(9):1452-60. doi: 10.1158/1541-7786.MCR-08-0066. Epub 2008 Aug 22.

20.

Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization.

Kawamura H, Li X, Goishi K, van Meeteren LA, Jakobsson L, Cébe-Suarez S, Shimizu A, Edholm D, Ballmer-Hofer K, Kjellén L, Klagsbrun M, Claesson-Welsh L.

Blood. 2008 Nov 1;112(9):3638-49. doi: 10.1182/blood-2007-12-125856. Epub 2008 Jul 29.

21.

Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.

van Meeteren LA, Brinkmann V, Saulnier-Blache JS, Lynch KR, Moolenaar WH.

Cancer Lett. 2008 Aug 8;266(2):203-8. doi: 10.1016/j.canlet.2008.02.052. Epub 2008 Apr 18.

22.

Regulation and biological activities of the autotaxin-LPA axis.

van Meeteren LA, Moolenaar WH.

Prog Lipid Res. 2007 Mar;46(2):145-60. Epub 2007 Mar 16. Review.

PMID:
17459484
23.

Upregulation of cytokine expression in fibroblasts exposed to loxosceles sphingomyelinase D: what is the trigger?

van Meeteren LA, Stortelers C, Moolenaar WH.

J Invest Dermatol. 2007 May;127(5):1266-7; author reply 1267-8. Epub 2007 Mar 8. No abstract available.

24.

Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma.

Savaskan NE, Rocha L, Kotter MR, Baer A, Lubec G, van Meeteren LA, Kishi Y, Aoki J, Moolenaar WH, Nitsch R, Bräuer AU.

Cell Mol Life Sci. 2007 Jan;64(2):230-43.

PMID:
17192809
25.

Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.

van Meeteren LA, Ruurs P, Stortelers C, Bouwman P, van Rooijen MA, Pradère JP, Pettit TR, Wakelam MJ, Saulnier-Blache JS, Mummery CL, Moolenaar WH, Jonkers J.

Mol Cell Biol. 2006 Jul;26(13):5015-22.

26.

Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity.

Ferguson CG, Bigman CS, Richardson RD, van Meeteren LA, Moolenaar WH, Prestwich GD.

Org Lett. 2006 May 11;8(10):2023-6.

27.

Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.

Durgam GG, Virag T, Walker MD, Tsukahara R, Yasuda S, Liliom K, van Meeteren LA, Moolenaar WH, Wilke N, Siess W, Tigyi G, Miller DD.

J Med Chem. 2005 Jul 28;48(15):4919-30.

PMID:
16033271
28.

Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate.

van Meeteren LA, Ruurs P, Christodoulou E, Goding JW, Takakusa H, Kikuchi K, Perrakis A, Nagano T, Moolenaar WH.

J Biol Chem. 2005 Jun 3;280(22):21155-61. Epub 2005 Mar 15.

29.

The ins and outs of lysophosphatidic acid signaling.

Moolenaar WH, van Meeteren LA, Giepmans BN.

Bioessays. 2004 Aug;26(8):870-81. Review.

PMID:
15273989
30.

Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine.

van Meeteren LA, Frederiks F, Giepmans BN, Pedrosa MF, Billington SJ, Jost BH, Tambourgi DV, Moolenaar WH.

J Biol Chem. 2004 Mar 19;279(12):10833-6. Epub 2004 Jan 19.

31.

Lysophosphatidic acid: mitogen and motility factor.

van Leeuwen FN, Giepmans BN, van Meeteren LA, Moolenaar WH.

Biochem Soc Trans. 2003 Dec;31(Pt 6):1209-12. Review.

PMID:
14641027
32.

Hydrogen peroxide inhibits cell cycle progression by inhibition of the spreading of mitotic CHO cells.

Muñoz CM, van Meeteren LA, Post JA, Verkleij AJ, Verrips CT, Boonstra J.

Free Radic Biol Med. 2002 Oct 15;33(8):1061-72.

PMID:
12374617

Supplemental Content

Loading ...
Support Center